BLUGLASS COMPLETES ENTITLEMENT OFFER

Highlights

  • BluGlass has completed an Entitlement Offer to existing shareholders, raising $470,000
  • Funds will be used to scale BluGlass’ product delivery to meet growing demand and expand its laser portfolio to address new markets
  • Allotment of shares expected to occur on 6 April 2023

Global semiconductor developer BluGlass Limited (ASX: BLG) has closed its non-renounceable Entitlement Offer, raising $470,000 before costs. The Entitlement Offer enabled eligible shareholders to purchase new BluGlass shares on a 1:30 basis at $0.06 per share. It followed a strongly supported $10.2 million Placement to institutional and sophisticated investors (as announced to ASX on 13 March 2023).

Funds will be used for additional fab equipment to scale BluGlass’ product delivery to meet growing demand, and expansion of its gallium nitride (GaN) laser portfolio to address new markets and applications.

BluGlass CEO Jim Haden said, “Our strengthened balance sheet allows us to invest in new capabilities and equipment to execute on our commercial roadmap. Our continued vertical integration is key to the ongoing improvement and expansion of our laser offering and drives margin growth over the long-term. Funds will also facilitate the development of higher-value, higher-margin products to address new markets and applications. Finally, I want to thank our loyal shareholders for your ongoing support. With your help, we are well on our way to building market share within a fast-growing market with few competitors and constrained supply.”

As outlined in the rights issue offer booklet, the Company now has a period of three months to place all or part of the rights issue shortfall. The Company has commenced discussions with a number of investors in relation to the rights issue shortfall.

Expected allotment of new shares is expected to occur no later than 11 April 2023 with the issue of 7,820,524 fully paid ordinary shares.

BluGlass logo
About BluGlass

Developing leading-edge semiconductor manufacturing technology and devices for more than a decade, BluGlass Limited (ASX:BLG) is a provider to the global GaN photonics industries, delivering cutting-edge, custom laser diode and LED development across the industrial, defence, display, and scientific markets.

Listed on the ASX, we are an Australian public company established to power the smarter, cleaner, more efficient photonics of tomorrow with our proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing technology.

Backed by an extensive network of supply-chain partners, BluGlass is developing a suite of laser diode products, from small batch custom lasers through to high-volume and off the shelf products.

For more information, please contact:

Stefanie Winwood +61 2 9334 2300 swinwood@bluglass.com